Fuwai Hospital, National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100037, China
NCT Number: NCT07816146
This study aims to conduct a second round of multicenter, prospective registry research targeting elderly patients with valvular heart disease, to understand the current status of interventions for patients with valvular heart disease. To systematically evaluate the distribution of types, clinical characteristics, interventions, and complications of elderly valvular heart disease, and to compare and analyze these with the China-DVD data from 2016, thereby revealing its evolutionary trends. By comprehensively considering various clinical characteristics such as different types of valvular lesions, treatment modalities, patient cardiac function, comorbidities, and blood test indicators, as well as multidimensional factors including psychological and lifestyle aspects, to deeply identify the key determinants influencing the treatment of elderly valvular heart disease patients in China, and thus optimize and improve their individualized comprehensive management pathways.
Trial opening soon.
Get Notified60 year and older
All sexes
Observational
Beijing, Beijing Municipality, 100037, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Hospitalized patients over 60 years old meet one of the following conditions.
1、 moderate or above valvular heart disease as defined by echocardiography: One of the following criteria
Exclusion criteria
Patients unwilling to accept registration and follow-up;
Time frame: From enrollment to the end of treatment at 12 weeks
Underwent their first internal medicine intervention or surgical procedure during hospitalization for valvular heart disease in this study
Time frame: From enrollment to the 12-month follow-up endpoint
1 、Repeat valve intervention : After the first valve intervention, the patient receives another valve surgical or interventional procedure due to valvular-related causes.
2、Cardiovascular adverse events : Any new-onset or recurrent cardiovascular disease, rehospitalization for cardiovascular reasons, and cardiac death, etc.
Trial opening soon.
Get NotifiedYongjian Wu, MD, PhD
Other Gov
Third National Multicenter Registered Cohort Study of Hospitalized Elderly Patients With Valvular Heart Disease Based on the China-DVD Network
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06458907
Cardiovascular Diseases, Heart Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07721584
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT07687485
Cardiovascular Diseases, Cardiovascular Diseases (CVD)
View Trial DetailsNCT07684313
Cardiovascular Diseases, Heart Diseases
Carmel, Indiana, United States
View Trial Details